BRD Symposium

Vaccination for respiratory immunity

In the last 20 years there have been tremendous advancements in immunology and biotechnology which are now being utilized to develop novel cattle respiratory vaccines. FULL STORY »

Antimicrobials and BRD

Pharmacokinetics/pharmacodynamics are helpful in drug development and regimen adjustment for refractive or extralabel applications. FULL STORY »

Future cattle health research

To help answer the question about future federal funding for cattle health research, we begin by examining past and current fiscal allocations from the USDA-Agricultural Research Service and USDA-Cooperative State Research, Education, and Extension Service for cattle disease activities. FULL STORY »

Future BRD research

BRD costs the U.S. beef producers up to $2 billion in losses annually (University of Arkansas, 2003). FULL STORY »

BRD research needs

There have been numerous significant advances realized through bovine infectious disease research. However, BRD remains a significant disease threat and a cause of tremendous loss. FULL STORY »

BRD bacterial pathogenesis

Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Arcanobacterium pyogenes, Mycoplasma bovis, and most recently, Bibersteinia trehalosi, are associated with severe bacterial pneumonia frequently seen in dairy calves (enzootic pneumonia) and in feedlot cattle (shipping fever). FULL STORY »

BRD losses inconsistent over the years

Del Miles, DVM, MS, Veterinary Research & Consulting Services LLC, Greeley, Colo., says the North American cattle industry has endured many changes throughout the years, but is no doubt encountering some of the most dramatic challenges in history during the first decade of the 21st century. FULL STORY »

Prev 1 2 Next